About Miltenyi Biotec

Empowering cell research.
Enabling cell therapy.

For almost 30 years, Miltenyi Biotec has played an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.

  • 1989 Miltenyi Biotec was founded in Germany

  • 14,000 products available worldwide

  • >2,000 employees worldwide

  • 475 employees in R&D, engineering, and clinical development

  • >50 nationalities represented within our staff

  • 28 countries with direct sales

  • 73 countries served through distributors

  • 2,500 patients treated annually with cell products using Miltenyi Biotec technologies

  • >55,000 cell therapy procedures with Miltenyi Biotec products

We look back at three decades of biomedical expertise and Pioniergeist. Throughout this time, we have continuously worked on the advancement of our technologies and collaborated with researchers around the world to push the boundaries of what is technically possible. 

  • 1989 – Foundation of Miltenyi Biotec
  • 1990 MACS® Technology patent
  • 1992 – CliniMACS® System developed
  • 1997 CliniMACS® System CE-marked
  • 2002 – GMP manufacturing facility opens in Teterow
  • 2008 – Introduction of MACSQuant® Analyzers
  • 2012 – Launch of CliniMACS Prodigy®
  • 2014 – FDA approval CliniMACS® CD34 Reagent
  • 2014 – Acquisition Lentigen Inc.
  • 2014 – Acquisition Owl Biomedical Inc.
  • 2016 – CliniMACS Prodigy T cell transduction (TCT) process
  • 2017 – GMP Process development in Sunnyvale
  • 2017 – Acquisition Sensovation AG
  • 2017 – Opening of the CliniMACS® Cell Factory
  • 2018 - Acquisition LaVision BioTec GmbH

At the heart of our business lies MACS Technology, a magnetic cell separation method based on the use of MACS Columns and MACS MicroBeads. Due to the gentle and effective nature of this method, isolated cell populations of interest are highly viable and pure. They can be used for a wide array of downstream applications including different research as well as clinical applications. Find out more about MACS Technology